Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Rating) Director David S. Tierney sold 30,000 shares of the business’s stock in a transaction on Wednesday, April 5th. The shares were sold at an average price of $16.83, for a total transaction of $504,900.00. Following the sale, the director now owns 313,541 shares of the company’s stock, valued […]
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Rating) insider Carmen Jeffrey Del sold 40,000 shares of the stock in a transaction that occurred on Wednesday, March 29th. The stock was sold at an average price of $16.70, for a total transaction of $668,000.00. Following the sale, the insider now owns 7,541 shares in the company, valued […]
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Rating) insider Carmen Jeffrey Del sold 40,000 shares of the company’s stock in a transaction dated Wednesday, March 29th. The shares were sold at an average price of $16.70, for a total transaction of $668,000.00. Following the sale, the insider now owns 7,541 shares of the company’s stock, valued […]
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Rating) CFO Alicia Grande sold 41,784 shares of the firm’s stock in a transaction on Wednesday, March 22nd. The shares were sold at an average price of $16.50, for a total transaction of $689,436.00. Following the completion of the transaction, the chief financial officer now owns 50,557 shares in […]
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Rating) insider Brian Elsbernd sold 50,000 shares of Catalyst Pharmaceuticals stock in a transaction dated Monday, March 20th. The shares were sold at an average price of $16.07, for a total value of $803,500.00. Following the completion of the sale, the insider now directly owns 138,076 shares in the […]